Literature DB >> 23165408

Prevalence and clinical characteristics of adult patients with congenital heart disease in Tuscany.

Silvia Favilli1, Gennaro Santoro, Piercarlo Ballo, Chiara Arcangeli, Francesco M Bovenzi, Enrico Chiappa, Umberto Conti, Anna Monopoli, Bruno Murzi, Costanza Rosini, Alfredo Zuppiroli.   

Abstract

AIMS: The clinical features of the adult population with congenital heart disease (CHD) are still not well characterized, particularly in the subset with more severe lesions. We report the data collected in the National Association of Hospital Cardiologists Toscana grown-up CHD (GUCH) registry over its first 8-month enrolment period.
METHODS: The Registry included consecutive patients aged more than 16 years with a documented diagnosis of CHD, enrolled in seven different Tuscan hospitals using a web-based electronic form. Severe CHD was defined as cyanotic CHD, or acyanotic lesion with significant haemodynamic impact requiring surgical and/or percutaneous correction.
RESULTS: Between November 2009 and June 2010 a total of 1641 patients (mean age 41.8 ± 19.3 years, 52.2% women) were enrolled. Atrial septal defect was the most common lesion, accounting for more than one-third of cases. Atrial and ventricular septal defects together accounted for about half of all CHDs. Nearly one-third of patients had New York Heart Association (NYHA) class 2 or more. A history of recurrent arrhythmias was reported in 15% of cases, and 12% of patients were on oral anticoagulants at the time of enrolment. The prevalence of pulmonary hypertension was 6%, and the prevalence of Eisenmenger syndrome was 1.2%. Severe CHD was present in 42% of patients. Younger age, higher NYHA class, male sex, and the need for oral anticoagulants were the only independent predictors of severe CHD.
CONCLUSION: Information about the clinical characteristics and the CHD type distribution of a sample of Tuscan GUCH population was provided. Severe CHD accounts for about 40% of all CHDs in this population. CHD severity is associated with younger age, male gender, worse NYHA class, and need for oral anticoagulation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23165408     DOI: 10.2459/JCM.0b013e3283569b3a

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  4 in total

1.  Advanced therapies in patients with congenital heart disease-related pulmonary arterial hypertension: results from a long-term, single center, real-world follow-up.

Authors:  Silvia Favilli; Gaia Spaziani; Piercarlo Ballo; Veronica Fibbi; Gennaro Santoro; Enrico Chiappa; Chiara Arcangeli
Journal:  Intern Emerg Med       Date:  2015-01-09       Impact factor: 3.397

2.  Exploring the lived experiences of pregnancy and early motherhood in Italian women with congenital heart disease: an interpretative phenomenological analysis.

Authors:  Serena Francesca Flocco; Rosario Caruso; Serena Barello; Tiziana Nania; Silvio Simeone; Federica Dellafiore
Journal:  BMJ Open       Date:  2020-01-23       Impact factor: 2.692

3.  Epidemiology and major subtypes of congenital heart defects in Hunan Province, China.

Authors:  Donghua Xie; Junqun Fang; Zhiyu Liu; Hua Wang; Tubao Yang; Zhenqiu Sun; Aihua Wang; Lili Xiong
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

4.  Pattern of un-operated Grown Up Congenital Heart (GUCH) patients presenting to a Tertiary Care Cardiac Institute of Punjab.

Authors:  Abdul Razzaq Mughal; Rubina Tousif; Asif Rashid Alamgir; Anjum Jalal
Journal:  Pak J Med Sci       Date:  2019 Jul-Aug       Impact factor: 1.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.